Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: A methodological overview

NeuroToxicology

Volumn 61, Issue , 2017, Pages 12-18

  Hersi, Mona ^a   Quach, Pauline ^a   Wang, Ming Dong ^a,b   Gomes, James ^a   Gaskin, Janet ^a   Krewski, Daniel ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHANGCHUN NORMAL UNIVERSITY   (China)

^c RISK SCIENCES INTERNATIONAL   (Canada)

Author keywords

AMSTAR; Data extraction; Meta analyses; Neurological disease; Risk factors; Systematic review

Indexed keywords

ATAXIN 2;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATXN2 GENE; C9ORF72 GENE; CAG REPEAT; GENE; GENE MUTATION; HUMAN; INCIDENCE; NEUROLOGIC DISEASE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SOD1 GENE; SYSTEMATIC REVIEW; TARDBP GENE; BIBLIOGRAPHIC DATABASE; DISEASE EXACERBATION; META ANALYSIS (TOPIC); STATISTICS AND NUMERICAL DATA;

DATABASES, BIBLIOGRAPHIC; DISEASE PROGRESSION; HUMANS; META-ANALYSIS AS TOPIC; NERVOUS SYSTEM DISEASES; RISK FACTORS;

EID: 84979673776     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2016.06.017     Document Type: Article

References (24)

1. Rx for Change: Methods for Development. (accessed 23.06.11.) http://www.cadth.ca/resources/rx-for-change/methods-for-development.
2. Couratier, P., Corcia, P., Lautrette, G., Nicol, M., Preux, P.M., Marin, B., Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev. Neurol. 172:1 (2016), 37–45.
3. Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Commun. Health 52 (1998), 377–384.
4. Gaskin, J., Gomes, J., Darshan, S., Krewski, D., Burden of neurological conditions in Canada. Neurotoxicology 61 (2017), 2–10.
5. Hersi, M., Irvine, B., Gomes, J., Krewski, D., Risk factors associated with the onset and progression of Alzheimer's disease: a systematic review of the evidence. Neurotoxicology 61 (2017), 143–187.
6. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Preamble. 2016, Lyon, France (accessed 24.05.16.). http://monographs.iarc.fr/ENG/Preamble/CurrentPreamble.pdf.
7. Krewski, D., Pringsheim, T., Tremlett, H., Barakat-Haddad, C., van Lieshout, P., Martino, R., Walsh, S.J., Gomes, J., Little, J., Determinants of neurological disease: synthesis of systematic reviews. Neurotoxicology 61 (2017), 266–289.
8. Little, J., Barakat-Haddad, C., Martino, R., Pringsheim, T., Tremlett, H., McKay, K., van Lieshout, P., Walsh, S.J., Gomes, J., Krewski, D., Genetic variation associated with the occurrence and progression of neurological disorders. Neurotoxicology 61 (2017), 243–264.
9. Moher, D., Tsertvadze, A., Systematic reviews: when an update is an update?. Lancet 367 (2006), 881–882.
10. National Research Council (NRC), Review of EPA's Integrated Risk Information System. 2014, National Academy Press, Washington, D.C.
11. Public Health Agency of Canada (PHAC), 2014a. Economic burden of illness in Canada, 2005–2008. March 2014, 111 pages. www.phac-aspc.gc.ca/publicat/ebic-femc/2005-2008/index-eng.php (accessed 18.12.15.).
12. Quach, P., El Sherif, R., Gomes, J., Krewski, D., A systematic review of the risk factors associated with the onset and progression of primary brain tumours. Neurotoxicology 61 (2017), 214–232.
13. Public Health Agency of Canada (PHAC), 2014b. Mapping connections: an understanding of neurological conditions in Canada. September 2014, 110 pages. www.phac-aspc.gc.ca/publicat/cd-mc/mc-ec/index-eng.php (accessed 18.12.15.).
14. Rhomberg, L.R., Goodman, J.E., Bailey, L.A., Prueitt, R.L., Beck, N.B., Bevan, C., Honeycutt, M., Kaminski, N.E., Paoli, G., Pottenger, L.H., Scherer, R.W., Wise, K.C., Becker, R.A., A survey of frameworks for best practices in weight-of-evidence analyses. Crit. Rev. Toxicol. 43 (2013), 753–784.
15. Shaikh, N., Badgett, R.G., Pi, M., Wilczynski, N.L., McKibbon, K.A., Ketchum, A.M., Haynes, R.B., Development and validation of filters for the retrieval of studies of clinical examination from Medline. J. Med. Internet Res., 13(4), 2011, e82.
16. Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., Henry, D.A., Boers, M., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J. Clin. Epidemiol. 62 (2009), 1013–1020.
17. Wang, M.-D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., A meta-analyses of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis (ALS). J Occup Environ. Med. 56 (2014), 1235–1242.
18. Wang, M.-D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., Intermediate CAG repeats extension in the AXTN2 gene is a unique genetic risk factor for ALS. PLoS One, 9, 2014, e105534.
19. White, C.M., Stanley, Ip M.D., McPheeters, M. et al., 2009. Using existing systematic reviews to replace de novo process in conditional Comparative Effectiveness Reviews. In Agency for Health Care Research and Quality Methods Guide for Comparative Effective Reviews, Rochville, MD.
20. Whitlock, E.P., Lin, J.S., Chou, R., et al. Using existing reviews in complex systematic reviews. Ann. Intern. Med. 148 (2008), 776–782.
21. Wigle, D.T., Arbuckle, T.E., Turner, M.C., Bérubé, A., Yang, Q., Liu, S., Krewski, D., Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J. Toxicol. Environ. Health B 11 (2008), 373–517.
22. Wigle, D.T., Turner, M.C., Krewski, D., A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. Environ. Health Perspect. 117 (2009), 1505–1513.
23. Yetley, E.A., MacFarlane, A.J., Green-Finestone, L.S., Garza, B.G., 2016. DRI Chronic Disease Working Group. Options for consideration of chronic disease endpoints for Dietary Reference Intakes (DRIs): summary report from a joint US/Canadian-sponsored expert panel. submitted for publication.
24. Young, M.M., Stevens, A., Porath-Waller, A., Pirie, T., Garritty, C., Skidmore, B., Turner, L., Arratoon, C., Haley, N., Leslie, K., Reardon, R., Sproule, B., Grimshaw, J., Moher, D., Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol. Syst. Rev., 1, 2012, 22.